Identifying and tackling PXE

Article

Pseudoxanthoma elasticum (PXE) is an inherited metabolic disease with many systemic manifestations. Although the skin changes are striking, the eye and cardiovascular lesions can be most devastating to the patient.

What are the symptoms?

Different forms of pattern dystrophy can be seen in patients with PXE, taking the form of fundus pulverulentus, butterfly-shaped dystrophy, reticular dystrophy and solitary vitelliform pattern dystrophy. However, it is not uncommon for a combination of these pathologies to be found in the same patient. Others may show progression from one pattern to another during follow-up.

How easy is it to diagnose?

It's been detected, so how do we treat it?

Once the diagnosis has been made, patients should be advised regarding eye protection for contact sports or physical activity as choroidal haemorrhage may occur following trivial ocular trauma, resulting in subfoveal haemorrhage and subsequent scarring, ultimately leading to vision loss.6,7

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.